ANPARIO PLC (ANP) — Interim Results for the six months to 30 June 2026

Investor webinar replay

Replay transcript excerpt

Yeah. Good afternoon, and welcome to the ANPARIO PLC investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and can be submitted at any time via the q and a tab situated on the right hand corner of your screen. Please just simply type in your questions and press send. Before we begin, I'd like to submit the following poll. I'd like to hand you over to Richard Edwards, CEO. Good afternoon, sir. Thank you. Yeah. Welcome to ANPARIO's interim results for the first half year of twenty twenty six. Well, Mark will run through the numbers initially, and then I will sort of go through the re some of the regional performances. I'm sure there'll be a lot of interest in some of what we said about Asia, mycotoxin binders. And then I'll I'll finish off with a little bit on sort of innovation, product development, and the outlook. And, hopefully, we'll have time for some questions towards the end once we finish the presentation. Mark, over to you then. Let's get it underway. Okay. Thanks everyone for joining. As Richard said, we've the agenda there. I walked through the finance section, the region, and then Rich will take over for the regional performance and innovation development. I'm sure you've seen the key highlights there, so I'll skip through to the first slide in my section. So let's just walk you through the P and L. Revenue increased 7% in the period to 24,300,000 coming on the back of a couple of years where we achieved higher growth than that, you know, both organically and inorganically. Thanks for the contribution from BioVet. But, know, it's still a really positive movement. You know, we target high single digit growth on a long term basis. And and some years will be better, and some some years ar...